Our results here reveal CD44 expression in 64.1% of laryngeal carcinomas, almost half of which exhibited lymph node metastases at the time of diagnosis, confirming its role in the selection of cancer stem cells, inducing disease progression and therapy resistance. This evidence concerns the gene CD44 and cancer.